2022
DOI: 10.1002/adma.202207870
|View full text |Cite
|
Sign up to set email alerts
|

An Implantable Magnetic Vascular Scaffold for Circulating Tumor Cell Removal In Vivo

Abstract: An integrated trapped device (ITD) capable of removal of circulating tumor cells (CTCs) can assuage or even prevent metastasis. However, adhesion repertoires are ordinarily neglected in the design of ITDs, possibly leading to the omission of highly metastatic CTC and treatment failure. Here a vascular‐like ITD with adhesive sites and wireless magnetothermal response to remove highly metastatic CTC in vivo is presented. Such a vascular‐like ITD comprises circumferential well‐aligned fibers and artificial adhesi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 52 publications
0
11
0
Order By: Relevance
“…10C, Yin et al proposed for the first time a vascular integrated trapped device (ITD), which is an implantable HA modified magnetic vascular stent (HA-MVS) for the permanent capture and magnetothermal ablation of CD44 positive (CD44+) CTCs under an alternating magnetic field (AMF). 152 The HA-MVS can capture CTCs repeatedly in a dynamic environment (flow rate = 5.0 mL min −1 ). In the setting of extracorporeal closed-loop circulation, the capture efficiency reached 21.6 ± 1.5% after 120 cycles, and 13.26 ± 4.22% in rats after 3 hours of in vivo circulation.…”
Section: Technologies For Ctc Enrichment In Vivomentioning
confidence: 99%
“…10C, Yin et al proposed for the first time a vascular integrated trapped device (ITD), which is an implantable HA modified magnetic vascular stent (HA-MVS) for the permanent capture and magnetothermal ablation of CD44 positive (CD44+) CTCs under an alternating magnetic field (AMF). 152 The HA-MVS can capture CTCs repeatedly in a dynamic environment (flow rate = 5.0 mL min −1 ). In the setting of extracorporeal closed-loop circulation, the capture efficiency reached 21.6 ± 1.5% after 120 cycles, and 13.26 ± 4.22% in rats after 3 hours of in vivo circulation.…”
Section: Technologies For Ctc Enrichment In Vivomentioning
confidence: 99%
“…Copyright 2022 American Chemical Society. Reprinted in part with permission from ref . Copyright 2022 John Wiley and Sons.…”
Section: Application Of Mgns As a Theranostic Platformmentioning
confidence: 99%
“…Specifically, a vascular‐like system containing adhesive sites and the wireless magnetothermal response was recently reported for the continuous capture and removal of CD44‐positive CTCs in vivo (Figure 3D). [ 52 ] The device was made of poly( l ‐lactic acid) fibers encapsulated with FeCo nanocrystals and modified with hyaluronic acid and gelatin to form artificial adhesion sites for capturing the cells. Cell death was accomplished through magnetothermal ablation under an alternating magnetic field.…”
Section: Implantable Cancer Traps For In Vivo Capturing Of Metastatic...mentioning
confidence: 99%
“…D) Scheme describing the step-by-step capture and removal of CD44+ CTCs by the vascular-like integrated trapped device. Reproduced with permission [52]. Copyright 2022, Wiley-VCH GmbH.…”
mentioning
confidence: 99%